惠廣纖維素醚事業(yè)部上海惠廣為營(yíng)銷(xiāo)中心成立于2003年,公司現(xiàn)有上海、山東兩大生產(chǎn)基地?；輳V纖維素醚事業(yè)部嚴(yán)格按照GMP規(guī)范要求建設(shè)生產(chǎn)基地,引進(jìn)了前沿的產(chǎn)品檢驗(yàn)檢測(cè)設(shè)備,擁有多條先進(jìn)的藥用輔料生產(chǎn)線。惠廣纖維素醚事業(yè)部,致力于醫(yī)藥級(jí)纖維素醚的研發(fā)、生產(chǎn)、銷(xiāo)售,為全球客戶(hù)提供優(yōu)質(zhì)的產(chǎn)品和解決方案

國(guó)家藥品監(jiān)督管理局藥品審評(píng)中心.藥用輔料備案登記號(hào)F20240000184

Huiguang Cellulose Ether Division was established in 2003, it has two major production bases located in Shanghai and Shandong. The plants were built according to GMP standard strictly, equipped with latest testing instruments and have multiple advanced pharmaceutical excipient production lines  Huiguang Cellulose Ether Division is committed to the research and development, production, and sales of pharmaceutical grade cellulose ether, providing high-quality products and solutions to  global customers.National Medical Products Administration Drug Evaluation Center . Medical excipient registration number F20240000184